These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 18799935

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
    Harel Z, Gold M, Cromer B, Bruner A, Stager M, Bachrach L, Wolter K, Reid C, Hertweck P, Nelson A, Nelson D, Coupey S, Johnson C, Burkman R, Bone H.
    J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205
    [Abstract] [Full Text] [Related]

  • 23. Serum markers of bone turnover in children and adolescents with classic galactosemia.
    Gajewska J, Ambroszkiewicz J, Radomyska B, Chełchowska M, Ołtarzewski M, Laskowska-Klita T, Milanowski A.
    Adv Med Sci; 2008 Jan; 53(2):214-20. PubMed ID: 18650146
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Bone status and adipokine levels in children on vegetarian and omnivorous diets.
    Ambroszkiewicz J, Chełchowska M, Szamotulska K, Rowicka G, Klemarczyk W, Strucińska M, Gajewska J.
    Clin Nutr; 2019 Apr; 38(2):730-737. PubMed ID: 29609869
    [Abstract] [Full Text] [Related]

  • 29. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
    Gunes AM, Can E, Saglam H, Ilçöl YO, Baytan B.
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
    [Abstract] [Full Text] [Related]

  • 30. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study.
    Arikoski P, Komulainen J, Riikonen P, Voutilainen R, Knip M, Kröger H.
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3174-81. PubMed ID: 10487683
    [Abstract] [Full Text] [Related]

  • 31. Decreased bone turnover markers in children on long-term parenteral nutrition (PN) for intestinal failure (IF).
    Derepas C, Kosar C, Avitzur Y, Wales PW, Courtney-Martin G.
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):85-94. PubMed ID: 23976773
    [Abstract] [Full Text] [Related]

  • 32. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids.
    Pańczyk-Tomaszewska M, Adamczuk D, Kisiel A, Skrzypczyk P, Przedlacki J, Górska E, Stelmaszczyk-Emmel A, Demkow U, Roszkowska-Blaim M.
    Adv Exp Med Biol; 2015 Jan; 840():21-8. PubMed ID: 25310960
    [Abstract] [Full Text] [Related]

  • 33. Shift of serum osteocalcin components between cord blood and blood at day 5 of life.
    Shimizu N, Shima M, Hirai H, Nakajima S, Nishimura K, Yamaoka K, Okada S.
    Pediatr Res; 2002 Nov; 52(5):656-9. PubMed ID: 12409510
    [Abstract] [Full Text] [Related]

  • 34. Effect of long-term oral anticoagulant therapy on bone mineral density and bone turnover markers: a prospective 12 month study.
    Stenova E, Steno B, Killinger Z, Baqi L, Payer J.
    Bratisl Lek Listy; 2011 Nov; 112(2):71-6. PubMed ID: 21456505
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls.
    Greer RM, Buntain HM, Potter JM, Wainwright CE, Wong JC, O'Rourke PK, Francis PW, Bell SC, Batch JA.
    Osteoporos Int; 2003 Jun; 14(5):404-11. PubMed ID: 12730764
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol.
    Inoue T, Sugiyama T, Matsubara T, Kawai S, Furukawa S.
    Endocr J; 2001 Feb; 48(1):11-8. PubMed ID: 11403096
    [Abstract] [Full Text] [Related]

  • 39. [Bone mineral density and markers of bone turnover in patients treated for malignant disease in childhood].
    Muszyńska-Rosłan K, Konstantynowicz J, Krawczuk-Rybak M, Łuczyński W, Kaczmarski M, Wołczynski S, Piotrowska-Jastrzebska J.
    Med Wieku Rozwoj; 2004 Feb; 8(4 Pt 2):1041-54. PubMed ID: 15951599
    [Abstract] [Full Text] [Related]

  • 40. Bone mineral density and metabolism in children with congenital hypothyroidism after prolonged L-thyroxine therapy.
    Leger J, Ruiz JC, Guibourdenche J, Kindermans C, Garabedian M, Czernichow P.
    Acta Paediatr; 1997 Jul; 86(7):704-10. PubMed ID: 9240877
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.